{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:39:52Z","timestamp":1793749192850,"version":"4.6.1"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.humpath.2022.08.006","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T06:41:24Z","timestamp":1662446484000},"page":"123-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges"],"prefix":"10.1016","volume":"136","author":[{"given":"Sambit K.","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandi","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-5293","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.08.006_bib1","series-title":"Urinary and male genital tumors","year":"2022"},{"key":"10.1016\/j.humpath.2022.08.006_bib2","series-title":"Urologic surgical pathology","author":"Cheng","year":"2020"},{"key":"10.1016\/j.humpath.2022.08.006_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00428-020-02752-5","article-title":"ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology","volume":"476","author":"Hang","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.08.006_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.humpath.2020.06.007","article-title":"Immunophenotypic and pathologic heterogeneity of unclassified renal cell carcinoma: a study of 300 cases","volume":"102","author":"Akgul","year":"2020","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib5","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.21037\/tau-20-1150","article-title":"Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review","volume":"10","author":"Cimadamore","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"12","key":"10.1016\/j.humpath.2022.08.006_bib6","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/PAS.0000000000000703","article-title":"Fumarase-deficient uterine leiomyomas: an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases","volume":"40","author":"Miettinen","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2022.08.006_bib7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib8","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-9440(10)61757-9","article-title":"Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology","volume":"159","author":"Kiuru","year":"2001","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2022.08.006_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2008.09.009","article-title":"Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms","volume":"40","author":"Cheng","year":"2009","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2022.08.006_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib11","series-title":"WHO classification of tumors of the urinary system and male genital organs","author":"Moch","year":"2016"},{"key":"10.1016\/j.humpath.2022.08.006_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.humpath.2019.09.009","article-title":"Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia","volume":"95","author":"MacLennan","year":"2020","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2022.08.006_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2022.08.006_bib14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (esc rcc): further morphologic and molecular characterization of esc rcc as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2022.08.006_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2022.08.006_bib16","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/his.13457","article-title":"Eosinophilic solid and cystic renal cell carcinomas have metastatic potential","volume":"72","author":"McKenney","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.08.006_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2018.05.023","article-title":"Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases","volume":"80","author":"Tretiakova","year":"2018","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2022.08.006_bib18","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (esc) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2022.08.006_bib19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic Bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.humpath.2022.08.006_bib20","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0000000000001476","article-title":"Report From the international society of urological pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer","volume":"44","author":"Williamson","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2022.08.006_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2022.08.006_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euf.2019.11.013","article-title":"Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course","volume":"7","author":"DiNatale","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"12","key":"10.1016\/j.humpath.2022.08.006_bib23","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/PAS.0000000000000513","article-title":"Do clear cell papillary renal cell carcinomas have malignant potential?","volume":"39","author":"Diolombi","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2022.08.006_bib24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.eururo.2020.09.027","article-title":"The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: implications in diagnosis and management","volume":"79","author":"Weng","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.08.006_bib24a","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/his.14071","article-title":"Defining clear cell papillary renal cell carcinoma in routine clinical practice","volume":"76","author":"Gupta","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.08.006_bib24b","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.eururo.2020.09.027","article-title":"Re: stanley Weng, Renzo G. DiNatale, Andrew Silagy, et al. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: implications in Diagnosis and Management","volume":"79","author":"Gupta","year":"2021","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.humpath.2022.08.006_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/PAS.0000000000001288","article-title":"Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study","volume":"43","author":"Al-Obaidy","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib26","unstructured":"Al-Obaidy KI, Saleeb RM, Trpkov K, et al. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity. Mod Pathol (in press) Online ahead of print. PMID: 35152262"},{"issue":"6","key":"10.1016\/j.humpath.2022.08.006_bib27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41379-019-0362-1","article-title":"Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity","volume":"33","author":"Al-Obaidy","year":"2020","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2022.08.006_bib27a","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2022.08.006_bib28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/PAS.0000000000001467","article-title":"Biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations","volume":"44","author":"Argani","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2022.08.006_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/PAS.0000000000000639","article-title":"Biphasic squamoid alveolar renal cell carcinoma: a distinctive subtype of papillary renal cell carcinoma?","volume":"40","author":"Hes","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0090-4295(96)00223-3","article-title":"Primary thyroid-like carcinoma of the kidney","volume":"48","author":"Angell","year":"1996","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.pas.0000194745.10670.dd","article-title":"Thyroid follicular carcinoma-like tumor of kidney: a case report with morphologic, immunohistochemical, and genetic analysis","volume":"30","author":"Jung","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/PAS.0b013e31818cb8f5","article-title":"Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm","volume":"33","author":"Amin","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2022.08.006_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/PAS.0000000000001846","article-title":"NF2-mutated renal carcinomas have common morphologic features which overlap with biphasic hyalinizing psammomatous renal cell carcinoma: a comprehensive study of 14 cases","volume":"46","author":"Paintal","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2022.08.006_bib34","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41379-021-00833-7","article-title":"EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma","volume":"34","author":"Al-Obaidy","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2020.01.004","article-title":"The applicability and utility of immunohistochemical biomarkers in bladder pathology","volume":"98","author":"Akgul","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib36","doi-asserted-by":"crossref","unstructured":"Moch H, Amin MB, Berney DM, et al. The 2022 World Health organization classification of tumours of the urinary system and male genital organs-Part A: renal, penile, and testicular tumours. Eur Urol (in press).","DOI":"10.1016\/j.eururo.2022.06.016"},{"key":"10.1016\/j.humpath.2022.08.006_bib37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12022-016-9444-5","article-title":"Neuroendocrine tumors of the urinary bladder according to the 2016 World Health organization classification: molecular and clinical characteristics","volume":"7","author":"Kouba","year":"2016","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2022.08.006_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12022-016-9421-z","article-title":"Neuroendocrine tumors of the prostate: emerging insights from molecular data and updates to the 2016 world health organization classification","volume":"27","author":"Priemer","year":"2016","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2022.08.006_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1470-2045(19)30738-7","article-title":"Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study","volume":"21","author":"Str\u00f6m","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41379-020-0640-y","article-title":"Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists","volume":"34","author":"Bulten","year":"2021","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2022.08.006_bib41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.urolonc.2022.03.003","article-title":"Artificial intelligence in prostate cancer: Definitions, current research, and future directions","volume":"40","author":"George","year":"2022","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/modpathol.2008.236","article-title":"TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas","volume":"22","author":"Lotan","year":"2009","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.euf.2017.12.003","article-title":"Integrative genomic analysis of coincident cancer foci implicates CTNNB1 and PTEN alterations in ductal prostate cancer","volume":"5","author":"Gillard","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"11","key":"10.1016\/j.humpath.2022.08.006_bib44","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/s41379-019-0297-6","article-title":"MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia","volume":"32","author":"Magers","year":"2019","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2022.08.006_bib45","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euf.2020.10.007","article-title":"Intraductal carcinoma of the prostate: pathogenesis and molecular perspectives","volume":"7","author":"Zong","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib46","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.21037\/tau-20-853","article-title":"Narrative review of prostate cancer grading systems: will the gleason scores be replaced by the grade groups?","volume":"10","author":"Montironi","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"5","key":"10.1016\/j.humpath.2022.08.006_bib47","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.eururo.2017.01.038","article-title":"From gleason grading system and high-grade tertiary patterns to grade groups and integrated quantitative gleason score","volume":"73","author":"Montironi","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2022.08.006_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity: an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge","year":"2022","journal-title":"Nature NPJ Precision Oncology"},{"key":"10.1016\/j.humpath.2022.08.006_bib49","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/PAS.0000000000001139","article-title":"PIN-Like (ductal) adenocarcinoma of the prostate","volume":"42","author":"Paulk","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2022.08.006_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/his.14224","article-title":"PIN-like ductal carcinoma of the prostate has frequent activating RAS\/RAF mutations","volume":"78","author":"Kaur","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.08.006_bib51","series-title":"Bladder pathology","author":"Cheng","year":"2012"},{"key":"10.1016\/j.humpath.2022.08.006_bib52","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1001\/jamaoncol.2016.7013","article-title":"Understanding the genetic landscape of small cell carcinoma of the urinary bladder and implications for diagnosis, prognosis and treatment","volume":"3","author":"Kouba","year":"2017","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.humpath.2022.08.006_bib53","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8","article-title":"Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.humpath.2022.08.006_bib54","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.juro.2013.11.056","article-title":"Mixed high and low grade bladder tumors--are they clinically high or low grade?","volume":"191","author":"Gofrit","year":"2014","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.humpath.2022.08.006_bib55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00345-014-1383-5","article-title":"Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome","volume":"33","author":"Schubert","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.humpath.2022.08.006_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2015.09.007","article-title":"Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder","volume":"47","author":"Reis","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jasc.2021.12.003","article-title":"We'll always have Paris the Paris system for reporting urinary cytology 2022","volume":"11","author":"Wojcik","year":"2022","journal-title":"J Am Soc Cytopathol"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib58","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.humpath.2022.08.006_bib59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","article-title":"Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"3","author":"Woo","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"10","key":"10.1016\/j.humpath.2022.08.006_bib60","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.3390\/cancers12102994","article-title":"Systematic review and meta-analysis of vesical imaging-reporting and data system (VI-RADS) inter-observer reliability: an added value for muscle invasive bladder cancer detection","volume":"12","author":"Del Giudice","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2022.08.006_bib61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.13734","article-title":"Staging of bladder cancer","volume":"74","author":"Magers","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.08.006_bib62","unstructured":"Paner GP, Smith SC, Hartmann A, et al. Flat intraurothelial lesions of the urinary bladder - do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities and how to handle in routine clinical practice. Mod Pathol (in press)"},{"issue":"1","key":"10.1016\/j.humpath.2022.08.006_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-001-0577-6","article-title":"Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the ancona international consultation","volume":"440","author":"Lopez-Beltran","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.08.006_bib64","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PAP.0000000000000308","article-title":"The genitourinary pathology society update on classification and grading of flat and papillary urothelial neoplasia with new reporting recommendations and approach to lesions with mixed and early patterns of neoplasia","volume":"28","author":"Amin","year":"2021","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2022.08.006_bib65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.humpath.2010.07.007","article-title":"Bladder cancer: translating molecular genetic insights into clinical practice","volume":"42","author":"Cheng","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.humpath.2021.04.001","article-title":"Molecular pathology of urothelial carcinoma","volume":"113","author":"Lopez-Beltran","year":"2021","journal-title":"Hum Pathol"},{"issue":"21","key":"10.1016\/j.humpath.2022.08.006_bib67","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.3390\/cancers13215500","article-title":"Molecular classification of bladder urothelial carcinoma using nanostring-based gene expression analysis","volume":"13","author":"Lopez-Beltran","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2022.08.006_bib68","article-title":"Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management","author":"Cheng","year":"2022","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2022.08.006_bib69","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41379-021-00776-z","article-title":"Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications","volume":"34","author":"Cheng","year":"2021","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2022.08.006_bib70","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/his.14675","article-title":"An introduction to the WHO 5th edition 2022 classification of testicular tumours","volume":"81","author":"Berney","year":"2022","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.humpath.2022.08.006_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41572-018-0029-0","article-title":"Testicular cancer","volume":"4","author":"Cheng","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.humpath.2022.08.006_bib72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2016.08.002","article-title":"Perspectives on testicular germ cell neoplasms","volume":"59","author":"Cheng","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib73","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/PAT.0b013e32835f3e1a","article-title":"Premalignancy of the testis and paratestis","volume":"45","author":"Emerson","year":"2013","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.humpath.2022.08.006_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/his.12958","article-title":"Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy","volume":"69","author":"Berney","year":"2016","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.humpath.2022.08.006_bib75","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/modpathol.2010.70","article-title":"Primitive neuroectodermal tumors in patients with testicular germ cell tumors usually resemble pediatric-type central nervous system embryonal neoplasms and lack chromosome 22 rearrangements","volume":"23","author":"Ulbright","year":"2010","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2022.08.006_bib76","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/PAS.0b013e3181d31f33","article-title":"Primary carcinoid tumors of the testis: a clinicopathologic study of 29 cases","volume":"34","author":"Wang","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2022.08.006_bib77","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1158\/1078-0432.CCR-07-4146","article-title":"Germ cell origin of testicular carcinoid tumors","volume":"14","author":"Abbosh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.08.006_bib78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.humpath.2016.11.004","article-title":"Comparative immunomorphology of testicular Sertoli and sertoliform tumors","volume":"61","author":"Mesa","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib78a","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.humpath.2018.05.001","article-title":"BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma","volume":"79","author":"Lee","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.04.009","article-title":"Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms","volume":"65","author":"Roth","year":"2017","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2022.08.006_bib80","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41379-021-00825-7","article-title":"Counting mitoses: SI(ze) matters","volume":"34","author":"Cree","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2019.11.005","article-title":"Gonadoblastoma: origin and outcome","volume":"100","author":"Roth","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.08.006_bib82","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/his.13387","article-title":"Classical gonadoblastoma: its relationship to the \u201cdissecting\u201d variant and undifferentiated gonadal tissue","volume":"72","author":"Roth","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.08.006_bib83","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.pathol.2020.04.011","article-title":"Gonadoblastoma in\u00a0individuals with a normal karyotype and no evidence of a disorder of sex development","volume":"52","author":"Roth","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2022.08.006_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153198","article-title":"Gonadoblastoma versus ovarian mixed germ cell-sex cord stromal tumor in women or girls with no evidence of a disorder of sex development: a problem in differential diagnosis","volume":"216","author":"Roth","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"5","key":"10.1016\/j.humpath.2022.08.006_bib85","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00428-020-02843-3","article-title":"Novel insights into the mixed germ cell-sex cord stromal tumor of the testis: detection of chromosomal aneuploidy and further morphological evidence supporting the neoplastic nature of the germ cell component","volume":"477","author":"Michalova","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.08.006_bib86","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2022.08.006_bib87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2017.09.011","article-title":"Complexity of the genomic landscape of renal cell carcinoma: implications for targeted therapy and precision immuno-oncology","volume":"119","author":"Sanfrancesco","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1016\/j.humpath.2022.08.006_bib88","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/14737159.2018.1490179","article-title":"Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer","volume":"18","author":"Cimadamore","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"10.1016\/j.humpath.2022.08.006_bib89","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.seminoncol.2020.09.002","article-title":"Immune checkpoints and their inhibitors: Reappraisal of a novel diagnostic and therapeutic dimension in the urologic malignancies","volume":"47","author":"Sardana","year":"2020","journal-title":"Semin Oncol"},{"issue":"4","key":"10.1016\/j.humpath.2022.08.006_bib90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/23808993.2021.1911638","article-title":"An update on immunotherapy in uro-oncology","volume":"6","author":"Cimadamore","year":"2021","journal-title":"Expert Rev Precision Med Drug Dev"},{"issue":"10","key":"10.1016\/j.humpath.2022.08.006_bib91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41585-020-0359-z","article-title":"Understanding genomics and the immune environment of penile cancer to improve therapy","volume":"17","author":"Aydin","year":"2020","journal-title":"Nat Rev Urol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:42:10Z","timestamp":1758645730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722002246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":95,"alternative-id":["S0046817722002246"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.08.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}